🔎 Trials Near Me

Akèy › Maladi fwa steatotik › Florid › Miami

Etid klinik pou Maladi fwa steatotik nan Miami, FL

16 etid pou Maladi fwa steatotik ap chèche patisipan nan sit nan ak bò kote Miami (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Ap rekriteFaz 3
  • 89bio Clinical Study Site, Miami
  • 89bio Clinical Study Site, Miami
  • 89bio Clinical Study Site, Miami
Laj 18 a 75 · Tout sèks · Mizajou Oct 5, 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Ap rekriteFaz 3
  • 89bio Clinical Study Site, Miami
Laj 18 a 80 · Tout sèks · Mizajou Oct 5, 2026 · NCT06318169

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Ap rekriteFaz 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
Laj 18 a 75 · Tout sèks · Mizajou Sep 30, 2026 · NCT07704892

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Ap rekriteFaz 2
  • Evolution Clinical Trials, Miami
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07527910

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Ap rekriteFaz 2
  • University of Miami Health System, Miami
Laj 18 a 75 · Tout sèks · Mizajou Sep 28, 2026 · NCT05832229

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Ap rekriteFaz 2
  • Genoma Research Group, Inc., Miami
  • Med Research of Florida, LLC, Miami
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Ap rekriteFaz 3
  • Evolution Clinical Trials, Miami
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Ap rekriteFaz 3
  • Akero Clinical Study Site, Miami
  • Akero Clinical Study Site, Miami
Laj 18 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

Ap rekriteFaz 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • ak 3 plis
Laj 18 a 75 · Tout sèks · Mizajou Sep 17, 2026 · NCT07221188

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Ap rekriteFaz 2
  • GSK Investigational Site, Miami
Laj 18 a 70 · Tout sèks · Mizajou Aug 3, 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Ap rekriteFaz 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • ak 4 plis
Laj 18 a 75 · Tout sèks · Mizajou Jul 27, 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Ap rekriteFaz 2
  • GSK Investigational Site, Miami
Laj 18 a 75 · Tout sèks · Mizajou Jul 8, 2026 · NCT06920043

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Ap rekriteFaz 1/2Volontè an sante akeyi
  • Genoma Research Group, Inc, Miami
  • Med Research of Florida, LLC, Miami
Laj 18 a 75 · Tout sèks · Mizajou Apr 16, 2026 · NCT05648214

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Ap rekriteEtid obsèvasyon
  • Clinical Pharmacology of Miami, Miami
Laj 18 a 75 · Tout sèks · Mizajou Aug 14, 2025 · NCT07122700

Etid Maladi fwa steatotik nan lòt vil

Lòt etid nan Miami

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.